Dexcom delivering results
Dexcom has presented promising results from two studies of continuous glucose monitors, including its next-generation G7 CGM, reports Drug Delivery Business. The first study –
Dexcom has presented promising results from two studies of continuous glucose monitors, including its next-generation G7 CGM, reports Drug Delivery Business. The first study –
Shares of Precigen have increased after the company’s Phase 1b/2a study of its AG019 ActoBiotics, designed to address the underlying cause of Type 1 diabetes.
Spirit Pharmacy is the UK’s only home delivery pharmacy offering tailored services for people living with diabetes. Their mission is to make accessing advice, education,
A food intelligence company has raised $4m in funding to start shipping its app which scans Abbott’s Freestyle Libre to help people monitor their blood
As reported by Zacks Equity Research in June 2021, Medtronic recently secured two back-to-back European regulatory approvals in the diabetes management space, the first for
Supermarkets in England will be banned from displaying unhealthy food and drinks at checkouts or using them in buy one, get one free offers as
More people with diabetes are moving towards wearables and virtual care, accelerated by the coronavirus pandemic, a survey conducted in the US has found. Pump
The tale of Lilly, Ypsomed and an automated insulin delivery (AID) system. Eli Lilly, one of the Big Three insulin makers that’s had its eyes
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals, diagnostics and diabetes
It’s taken a little while to get here but it’s here: the FreeStyle Libre 2 (FSL2) is available on the NHS for people who qualify